ZCMD vs. BPTSY, MBIO, ELOX, IONM, QNRX, BPTS, CWBR, VRPX, ARAV, and DKDCA
Should you be buying Zhongchao stock or one of its competitors? The main competitors of Zhongchao include Biophytis (BPTSY), Mustang Bio (MBIO), Eloxx Pharmaceuticals (ELOX), Assure (IONM), Quoin Pharmaceuticals (QNRX), Biophytis (BPTS), CohBar (CWBR), Virpax Pharmaceuticals (VRPX), Aravive (ARAV), and Data Knights Acquisition (DKDCA). These companies are all part of the "medical" sector.
Zhongchao (NASDAQ:ZCMD) and Biophytis (NASDAQ:BPTSY) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, dividends, institutional ownership, profitability, risk, community ranking, earnings, analyst recommendations and valuation.
1.7% of Zhongchao shares are owned by institutional investors. Comparatively, 0.1% of Biophytis shares are owned by institutional investors. 28.6% of Zhongchao shares are owned by insiders. Comparatively, 3.7% of Biophytis shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
In the previous week, Zhongchao had 1 more articles in the media than Biophytis. MarketBeat recorded 1 mentions for Zhongchao and 0 mentions for Biophytis. Zhongchao's average media sentiment score of 0.49 beat Biophytis' score of 0.00 indicating that Zhongchao is being referred to more favorably in the media.
Zhongchao and Biophytis both received 0 outperform votes by MarketBeat users.
Zhongchao has a beta of 0.21, indicating that its stock price is 79% less volatile than the S&P 500. Comparatively, Biophytis has a beta of 1.14, indicating that its stock price is 14% more volatile than the S&P 500.
Zhongchao has higher revenue and earnings than Biophytis.
Summary
Zhongchao beats Biophytis on 6 of the 7 factors compared between the two stocks.
Get Zhongchao News Delivered to You Automatically
Sign up to receive the latest news and ratings for ZCMD and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ZCMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Zhongchao Competitors List
Related Companies and Tools
